Cullinan Therapeutics, Inc. · NASDAQ:CGEM
T. Rowe Price Associates Inc reported a 6.20% stake in Cullinan Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
T. Rowe Price Associates Inc reported a 6.20% stake in Cullinan Therapeutics, Inc., 3,825,950 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 3,825,950
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 6.20% | 3,825,950 |
Source
Related
- Cullinan Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Cullinan Therapeutics, Inc. shareholders
- Form 4 · Michaelson Jennifer · Sep 10, 2026
- Form 4 · Michaelson Jennifer · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Michaelson Jennifer · Jul 7, 2026